STOCK TITAN

Body and Mind Inc - BMMJ STOCK NEWS

Welcome to our dedicated news page for Body and Mind (Ticker: BMMJ), a resource for investors and traders seeking the latest updates and insights on Body and Mind.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Body and Mind's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Body and Mind's position in the market.

Rhea-AI Summary
Body and Mind Inc. (BMMJ) announces financial results for Q2 FY2024, with revenue of $4.4 million and a net loss of $0.2 million. The company divests its Nevada operations for $2 million to focus on Illinois and New Jersey projects. Management aims to improve financial performance and margins.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.38%
Tags
-
Rhea-AI Summary
Body and Mind Inc. (BMMJ) announces updates on its dispensary development schedules and the divestment of cultivation and processing operations in Nevada. The company is progressing with construction projects in Illinois and New Jersey, while divesting its Nevada assets to a third party for $2 million. The divestment is part of the company's strategy to prioritize its operational focus on high-return projects. Additionally, the company plans to issue 2,700,393 shares to Bengal Impact Partners, LLC as partial payment for advisory services provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
-
Rhea-AI Summary
Body and Mind Inc. (BMMJ) has received approval for an Annual Class 5 Cannabis Retailer license to operate in New Jersey, allowing the company to advance its dispensary development in Lawrenceville. With only 48 dispensaries in the state, the New Jersey market offers significant growth potential for the company. CEO Michael Mills expressed excitement about the approval and highlighted the team's motivation to deliver strong performance in the retail sector.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) has received final approval from the Illinois Department of Financial and Professional Regulation for the ownership of NMG IL4, LLC, a subsidiary that owns the assets of the Markham, Illinois dispensary. The dispensary, opened in April 2023, is strategically located near major highways and has seen increasing customer traffic and transactions. It offers a wide range of cannabis products and convenient online ordering for expedited pickup.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
none
-
Rhea-AI Summary
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) announced financial results for Q1 FY2024, including a 7% reduction in revenue compared to Q1 FY2023, positive net income of $0.2 million, and improved gross margin of 37.4%. The company also provided operational updates and highlights, such as the sale of the Ohio dispensary and repayment of senior secured debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
-
Rhea-AI Summary
Body and Mind Inc. (BaM) has closed the Long Beach asset purchase transaction, releasing 1,030,032 shares to the seller and returning 1,650,974 shares to the company's treasury.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) reports annual revenue of US$22.8 million for the fiscal year ended July 31, 2023. The company also highlights recent developments, including financial results, operational updates, and future priorities. Key financial figures include a net loss of $20.6 million and adjusted EBITDA loss of $6.0 million for FY 2023. The company is focusing on streamlining assets, entering the New Jersey market, expanding in the Illinois market, optimizing existing operations, and pursuing new expansion opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.5%
Tags
-
Rhea-AI Summary
Body and Mind Inc. closes Ohio dispensary transaction and repays debt
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
-
Rhea-AI Summary
Body and Mind Inc. provides corporate update, including divestment of Ohio processing operation, construction of Lynnwood dispensary in Illinois, and finalization of building plans for New Jersey dispensary.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
none
Rhea-AI Summary
Body and Mind Inc. announces the sale of its Ohio dispensary to FarmaceuticalRX, LLC for a total consideration of US$8.225 million in cash proceeds at closing with an additional US$2.5 million in potential contingent proceeds. The sale will improve the company's balance sheet and provide flexibility for strategic growth initiatives in New Jersey and Illinois.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Body and Mind Inc

OTC:BMMJ

BMMJ Rankings

BMMJ Stock Data

9.64M
130.16M
8.16%
5.3%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
Canada
Vancouver